Relmada Therapeutics Inc. (RLMD)

[Biobonic]

New article on Relmada on Biospace

Relmada Therapeutics Developing REL-1017 to Treat Major Depression
Published: Apr 21, 2020 By Gina Hagler

here

“We believe that REL-1017, if approved, has the potential to change the way depression is treated. This will change the lives of many people,” Traversa said. “We also believe that our proof-of-concept data from our Phase II trial of REL-1017 is very compelling. We are now focused on generating additional clinical data with REL-1017 and moving toward a registration program with the product expected to start at the end of this year.”